Replies to post #3029 on Ayala Pharmaceuticals Inc (ADXS)

[terry hallinan]

Thanks a whole heap, Inveterate.

That is the only possible explanation that makes any sense.

You leave me only an impossible explanation concerning an abysmally dense management.

But I am up to it even after discarding the ludicrous notion that Advaxis is looking to make an acquisition. Biotechs are black holes for cash in their start-up years and ADXS is entering the period of maximum expense with no product revenue possible in the near future. Even I can't stretch imagination that far.

It is all too common for biotechs on the make to release good news and then after a spike fill the old feedbag for the future.

There was no spike on extraordinarily good news but turning management away from faulty plans is probably harder than turning a horse away from a straight path to the barn after a long day. When I was a kid, I bloodied poor old Lizzie's mouth with a cruel Spanish bit trying and had to give up. Our CEO kept beating the horse even when it appeared dead.

Sure hope the CEO has learned a lesson. If so, all is far from lost.

All JMO.

Best, Terry